CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment.
Noga SJ, Seber A, Davis JM, Berenson RJ, Vogelsang GB, Braine HG, Hess AD, Marcellus D, Miller CA, Sharkis SJ, Goodman SN, Santos GW, Jones RJ.
Noga SJ, et al.
J Hematother. 1998 Apr;7(2):151-7. doi: 10.1089/scd.1.1998.7.151.
J Hematother. 1998.
PMID: 9597572
Clinical Trial.